相关实验视频

Updated: Sep 16, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

在复发和不可切除的内胆管放射频率切除中,Perihilar cholangiocarcinoma

Apiwat Jareanrat^1,2, Vasin Thanasukarn^1,2, Tharatip Srisuk^1,2

¹Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

BMC gastroenterology

|July 6, 2025

概括

结合自扩展金属支架 (SEMS) 的内胆管射频切除术 (EBRFA) 是可行的,用于不可切除的周周胆管胆瘤 (pCCA). 与单独使用SEMS相比,这种息方法在支架穿透率或存活率上没有显著差异.

科学领域:

胃肠病学胃肠病学
在瘤学瘤学.
干预性内镜检查是干预性的内镜检查.

背景情况:

息性胆道支架是与黄相伴不可切除的周围胆道胆道癌 (pCCA) 的标准.
胆管内射频移除 (EBRFA) 是胆管支架用于胆管癌 (CCA) 的新补充剂.
关于EBRFA在pCCA中的安全性和有效性的证据有限.

研究的目的:

研究EBRFA在pCCA患者中的安全性.
评估EBRFA在延长支架通透性的有效性.
评估EBRFA对患者存活率的影响.

主要方法:

在pCCA患者中,前性随机试验比较EBRFA与自扩展金属支架 (SEMS) 与单独使用SEMS.
在阻塞性黄复发之前记录了支架穿透性.
使用Log-rank和Chi-square测试分析的中位生存时间 (MST),中位支架通透率和不良事件率.

主要成果:

包括39名患者 (22名EBRFA,17名SEMS).
两组之间与手术相关并发症发生率没有显著差异.
支架穿透率 (71 vs. 78天,p=0.809) 和整体存活率 (94 vs. 79天,p=0.735) 相似.

结论:

对于不可切割的pCCA,EBRFA与SEMS安置相结合是程序上可行的.
这种组合表明可接受的结果作为息治疗选择.
进一步的研究可能会澄清EBRFA在pCCA管理中的作用.

关键词:

胆性瘤是一种胆性瘤.输卵管的射频剥离是指输卵管的射频剥离.克拉茨金的瘤是一个瘤.金属胆道支架金属胆道支架阻塞性黄是一种阻塞性黄.息治疗是一种息治疗.随机试验是指随机的试验.不能切割的治疗方法

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

相关概念视频

Endoscopic Procedures V: ERCP

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...